Zhen Liang

3.4k citations
79 papers · 2.5k indexed · h-index 30
Topics
MicroRNA in disease regulation (12 papers)Prostate Cancer Treatment and Research (12 papers)Prostate Cancer Diagnosis and Treatment (10 papers)

In The Last Decade

Zhen Liang

77 papers receiving 2.5k citations

Peers

Zhen Liang
Comparison fields: 5 of 134
  • Molecular Biology 1.2k
  • Cancer Research 826
  • Pulmonary and Respiratory Medicine 461
  • Oncology 357
  • Organic Chemistry 291
Replace Xueqiong Zhu with:
Xueqiong Zhu China
Huihui Zhang China
Mansoor Ali Syed India
Tse‐Hung Huang Taiwan
Yuanyuan Jiang China
Amir Abbas Momtazi‐Borojeni Iran
Nicole G. Hansbro Australia
Elisabetta Pace Italy
Teresa Puig Spain
Zhen Liang relative to Xueqiong Zhu China Xueqiong Zhu's profile →
Citations per field
00.5×3.9×
Xueqiong Zhu · 1×
Citations per year

Countries citing papers authored by Zhen Liang

Since Specialization
Citations

This map shows the geographic impact of Zhen Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Liang more than expected).

Fields of papers citing papers by Zhen Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Liang. The network helps show where Zhen Liang may publish in the future.

Co-authorship network of co-authors of Zhen Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Liang. A scholar is included among the top collaborators of Zhen Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Liang. Zhen Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 6
5 2
6 28
7 3
8 11
9 36
10 2
11 2
12 4
13 11
14 3
15 15
16 57
17 282
18 11
19 58
20
The therapeutic effects of irrigating therapy with magnolia injection on chronic maxillary sinusitis experimentally induced among rabbits
2

About Zhen Liang

Zhen Liang is a scholar working on Microbiology, Geriatrics and Gerontology and Cancer Research, having authored 79 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Prostate Cancer Treatment and Research (12 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). The work is most often cited by research in Cancer Research (826 citations), Microbiology (281 citations) and Molecular Biology (1.2k citations). Zhen Liang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xiao Wang, Xiangyi Zheng, Liping Xie, Xin Xu, Jian Wu, Shuai Meng, Ben Liu, Shiqi Li, Jiangfeng Li and Alin Ji. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026